Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide
- 31 March 1990
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 40 (3) , 264-267
- https://doi.org/10.1016/0090-8258(90)90289-w
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysisGynecologic Oncology, 1990
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987
- Melphalan, 5-Fluorouracil, and Medroxyprogesterone Acetate in Metastatic Endometrial CarcinomaObstetrics & Gynecology, 1986
- Treatment of recurent endometrial adenocarcinoma with a combination of doxorubicin and cisplatinAmerican Journal of Obstetrics and Gynecology, 1984
- Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimensCancer, 1982
- Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetateAmerican Journal of Obstetrics and Gynecology, 1981
- Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy☆Gynecologic Oncology, 1980
- Doxorubicin-cyclophosphamide: Effective chemotherapy for advanced endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1977
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960